Research map: Circulating CD90 +, CD133 +, and EpCAM + peripheral blood mononuclear cell populations in experimental liver fibrosis and hepatocellular carcinoma: association with disease severity

Back to the article

Papers in this map

  1. Albumin standards and the measurement of serum albumin with bromcresol green · Basil T. Doumas · 1971 · 3073 citations · Cited by this paper
  2. Studying serum immunoglobulin levels in metabolic dysfunction-associated steatotic liver disease · 2026 · Related
  3. Tumor-Associated Macrophages Produce Interleukin 6 and Signal via STAT3 to Promote Expansion of Human Hepatocellular Carcinoma Stem Cells · Shanshan Wan · 2014 · 693 citations · Cited by this paper
  4. Direct acting antiviral drugs reduce CXCL10 gene expression and reverse metabolic dysfunction in chronic HCV-infected patients · 2025 · Related
  5. Circulating stem cell–like epithelial cell adhesion molecule–positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection · Yun‐Fan Sun · 2012 · 413 citations · Cited by this paper
  6. Role of serum FGF21 in the diagnosis of metabolic dysfunction–associated fatty liver disease: a case–control study of Egyptian patients · 2025 · Related
  7. miR-130b Promotes CD133+ Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1 · Stephanie Ma · 2010 · 386 citations · Cited by this paper
  8. Exploring the role of peroxisome proliferator- activated receptor agonists (fenofibrate) in neonatal jaundice prevention · 2026 · Related
  9. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma · Taro Yamashita · 2012 · 286 citations · Cited by this paper
  10. Adjuvant anti-PD-L1 therapy for hepatocellular carcinoma following curative treatment: case series · 2026 · Related
  11. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma · Florie Borel · 2012 · 247 citations · Cited by this paper
  12. Value and accuracy of pro-calcitonin versus C-reactive protein in diagnosis of bacterial infection in cirrhotic patients · 2026 · Related
  13. Expression and clinical significance of the stem cell marker CD133 in hepatocellular carcinoma · Wenjie Song · 2008 · 226 citations · Cited by this paper
  14. Evaluation of serum Apurinic/Apyrimidinic Endodeoxyribonuclease 1 (APEX1) Level in cholangiocarcinoma and hepatocellular carcinoma patients · 2026 · Related
  15. A mesenchymal‐like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells · Joan Fernando · 2014 · 120 citations · Cited by this paper
  16. Serum dipeptidyl peptidase-4 in chronic liver disease patients with osteoporosis · 2026 · Related
  17. Expression of CD133 confers malignant potential by regulating metalloproteinases in human hepatocellular carcinoma · Keisuke Kohga · 2010 · 96 citations · Cited by this paper
  18. Potential association between PNPLA3 rs738409 and hepatocellular carcinoma in Egyptian patients with type 2 diabetes mellitus · 2026 · Related
  19. The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study · Caecilia Hapsari Ceriapuri Sukowati · 2013 · 93 citations · Cited by this paper
  20. An assessment of treatment outcomes among hepatocellular carcinoma patients at Kenyatta National Hospital · 2026 · Related
  21. The miR‐200b–ZEB1 circuit regulates diverse stemness of human hepatocellular carcinoma · Shu‐Chun Tsai · 2017 · 48 citations · Cited by this paper
  22. Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma · Bo Hyun Kim · 2019 · 47 citations · Cited by this paper
  23. Sequential analysis and staging of a diethylnitrosamine-induced hepatocellular carcinoma in male Wistar albino rat model · Abdallah H. Fathy · 2017 · 42 citations · Cited by this paper
  24. Identification of Transmembrane Protein 98 as a Novel Chemoresistance-Conferring Gene in Hepatocellular Carcinoma · TP Ng · 2014 · 41 citations · Cited by this paper
  25. CD90 serves as differential modulator of subcutaneous and visceral adipose-derived stem cells by regulating AKT activation that influences adipose tissue and metabolic homeostasis · Zhenzhen Pan · 2019 · 31 citations · Cited by this paper
  26. Prediction of the Ki-67 marker index in hepatocellular carcinoma based on Dynamic Contrast-Enhanced Ultrasonography with Sonazoid · Zhe Huang · 2022 · 28 citations · Cited by this paper
  27. Immunohistochemical Expression and Clinical Significance of Suggested Stem Cell Markers in Hepatocellular Carcinoma · Jong Jin Sung · 2015 · 23 citations · Cited by this paper
  28. Expression of Cancer Stem Cell Markers EpCAM and CD90 Is Correlated with Anti- and Pro-Oncogenic EphA2 Signaling in Hepatocellular Carcinoma · Nobuhiko Asakura · 2021 · 23 citations · Cited by this paper
  29. Enhanced circulating transforming growth factor beta 1 is causally associated with an increased risk of hepatocellular carcinoma: a mendelian randomization meta-analysis · Weiqun Lu · 2016 · 22 citations · Cited by this paper
  30. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights · James B. Yu · 2023 · 21 citations · Cited by this paper
  31. Biomarkers for hepatocellular carcinoma based on body fluids and feces · Ming‐Cheng Guan · 2021 · 19 citations · Cited by this paper
  32. Uncovering the Heterogeneity and Clinical Relevance of Circulating Tumor-Initiating Cells in Hepatocellular Carcinoma Using an Integrated Immunomagnetic-Microfluidic Platform · Wen-Jing Zheng · 2022 · 15 citations · Cited by this paper
  33. Chromenopyrimidinone Controls Stemness and Malignancy by suppressing CD133 Expression in Hepatocellular Carcinoma · Yeonhwa Song · 2020 · 11 citations · Cited by this paper
  34. Prognostic and clinicopathological value of CD90 expression in cancer patients: a systematic review and meta-analysis · Hyun Min Koh · 2021 · 4 citations · Cited by this paper
  35. Targeting LRRC41 as a potential therapeutic approach for hepatocellular carcinoma · Jun Li · 2023 · 3 citations · Cited by this paper
  36. Utility of Immunohistochemical Expression of Ki-67 in Liver Cirrhosis and Hepatocellular Carcinoma · Barathi Gunabooshanam · 2020 · 1 citation · Cited by this paper

Source: OpenAlex (CC0)